Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|January 30, 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia PatientsJean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, et al.
BMJ Open|September 23, 2025
Reporting of environmental outcomes in randomised clinical trials: a protocol for a scoping reviewJohanne Juul Petersen, Linn Hemberg, Lehana Thabane, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 7, 2025
Feasibility of Bruton's Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient PerspectiveDeborah M Stephens, Chris Stewart, Liza Avruch, et al.
Scientific Reports|August 27, 2025
Cefiderocol-resistant pathogens in German hospital wastewater: a reservoir for multidrug resistanceTim Erler, Laura Carlsen, Jennifer Dengler, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2025
A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic MalignanciesMichal Kwiatek, Guru Subramanian Guru Murthy, Marc Hoffmann, et al.
The Lancet. Oncology|February 6, 2025
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyMichael Wang, Wojciech Jurczak, Marek Trneny, et al.
International Journal of Cancer|February 10, 2019
Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patientsSophia Stock, Rudolf Übelhart, Maria-Luisa Schubert, et al.
Frontiers in Immunology|October 24, 2018
Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic EffectsLei Wang, Ming Ni, Angela Hückelhoven-Krauss, et al.
BMJ Open|September 21, 2025
Protocol for development of SPIRIT and CONSORT extensions for reporting climate and environmental outcomes in randomised trials (SPIRIT-ICE and CONSORT-ICE)Johanne Juul Petersen, Linn Hemberg, Lehana Thabane, et al.
JCO Oncology Advances|February 7, 2025
Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 TrialQamar J Khan, Colleen Bohnenkamp, Taylor E Monson, et al.
Pageof 5